To assess the effects of MRPS16 knockdown on glioma cell proliferation in vivo, we intraperitoneally injected the MRPS16 knockdown glioma U87 cells into the BALB/c mice and then kept them for a period of 6 weeks. This evidence concerns the gene MRPS16 and central nervous system cancer.